Ozempic’s Success Is Bad News for Rivals

Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek Daily."Hosted by Carol Massar and Tim StenovecHear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/ ...  Show more

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF Wall Street traders betting on another solid corporate earnings season sent stocks higher despite lingering concerns about still-elevated energy price ...  Show more

Drugs like Ozempic are revolutionizing the treatment of obesity. The medications, originally used to treat diabetes, keep gaining attention as celebrities and other influencers describe taking them to lose weight quickly.

Dani Blum, a reporter for The Times, tells the st ...

Ozempic has fast become the buzzword for dramatic weight loss, and considering the results users have been reporting, it’s easy to see why. To discuss the supposed miracle drug, Piers Morgan has assembled an all-star panel of doctors and patients, including; Journalist and author ...  Show more

Ozempic and other drugs like it are being heralded as game changers for weight loss. Radio Atlantic host Hanna Rosin talks to Atlantic staff writer Olga Khazan about what it means that this medical intervention has arrived at a time when our society seems to be easing away from f ...  Show more

For decades, Big Food has been marketing products to people who can’t seem to stop eating, and now, suddenly, they can. The active ingredient in new drugs like Ozempic, Wegovy and Zepbound mimics a natural hormone that slows digestion and signals fullness to the brain.

A ...